Therapeutic Asset Ratings
234 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Irinotecan
glioblastoma
University of Cincinnati
P3
BB
(68)
(+)-VINCRISTINE
glioblastoma
University of Cincinnati
P3
BB
(68)
Lomustine
glioblastoma
Telix Pharmaceuticals (Innovations) Pty Limited
P3
BB
(67)
Inno-206
glioblastoma
Université de Sherbrooke
P2
BB
(64)
ETOPOSIDE
glioblastoma
Sichuan Honghe Biotechnology Co., Ltd.
P2/3
BB
(64)
Cyclophosphamide
glioblastoma
Jennifer Leddon
P4
B
(63)
Ipilimumab
glioblastoma
University College, London
P3
B
(63)
Nivolumab
glioblastoma
Duke University
P3
B
(63)
Paxalisib
glioblastoma
Institute of Cancer Research, United Kingdom
P2/3
B
(63)
Epirubicin
Glioblastoma
Jennifer Leddon
P4
B
(62)
Pembrolizumab
glioblastoma
Jennifer Leddon
P4
B
(62)
FILGRASTIM
glioblastoma
Massachusetts General Hospital
P3
B
(62)
Gm-Csf
glioblastoma
University of Florida
P3
B
(62)
Calcium folinate pentahydrate
Glioblastoma
Leaf Vertical Inc.
P3
B
(61)
Eloxatin
Glioblastoma
Leaf Vertical Inc.
P3
B
(61)
DEXAMETHASONE
glioblastoma
City of Hope Medical Center
P2
B
(61)
Everolimus
glioblastoma
Nationwide Children's Hospital
P2
B
(61)
DIANHYDROGALACTITOL
glioblastoma
Global Coalition for Adaptive Research
P2/3
B
(61)
Capecitabine
Glioblastoma
Northwell Health
P3
B
(60)
Ferumoxytol
glioblastoma
Jonsson Comprehensive Cancer Center
P3
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
glioblastoma
Sichuan Honghe Biotechnology Co., Ltd.
P2/3
B
(60)
Niraparib
glioblastoma
Ivy Brain Tumor Center
P3
B
(59)
Azeliragon
glioblastoma
Washington University School of Medicine
P2
B
(59)
Indoximod
glioblastoma
Theodore S. Johnson
P2
B
(59)
gsk1120212
glioblastoma
National Cancer Institute (NCI)
P4
B
(58)
Showing 1 to 25 of 234 assets
Previous
Page 1 of 10
Next
